Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Repower Asia Indonesia Tbk. (REAL) Price & Performance

Brigit Biofarmaka Teknologi Tbk.Trade
Repower Asia Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Brigit Biofarmaka Teknologi Tbk. vs Repower Asia Indonesia Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B), while Repower Asia Indonesia Tbk. trades at Rp53 (market cap 351.58B). The key difference: Repower Asia Indonesia Tbk. is far larger — about 2.1× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.

OBATREAL
Market Cap
164.65B351.58B
Indicative Equilibrium Price
52
Indicative Equilibrium Volume
843

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

OBAT
View details
REAL
View details

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT

About Repower Asia Indonesia Tbk.

PT Repower Asia Indonesia Tbk (the Company) was established based on Notarial Deed No. 04 of Titik Krisna Murti Wikaningsih, S.H., M.KN., dated March 13, 2011, a Notary in Bekasi.

Read more on REAL